Heartsciences selected to demonstrate myovista® wavecg™ at the united nations general assembly digital health symposium as a technology to radically transform healthcare

Southlake, tx, july 25, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences (nasdaq: hscs; hscsw) (“heartsciences” or the “company”), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced that the myovista® wavecgtm has been selected by the innovation value institute as a technology which can drive the radical transformation of healthcare and has been invited to demonstrate and discuss the myovista wavecg at the 4th digital health symposium at the united nations general assembly to be held in new york, usa in september 2024.
GM Ratings Summary
GM Quant Ranking